Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 8, p. 550, doi. 10.1038/cgt.2010.10
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2010 AND VI 17 AND IP 8
Results: 8
1
2
Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 8, p. 559, doi. 10.1038/cgt.2010.11
- By:
- Publication type:
- Article
3
Bleomycin/interleukin-12 electrochemogenetherapy for treating naturally occurring spontaneous neoplasms in dogs.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 8, p. 571, doi. 10.1038/cgt.2010.13
- By:
- Publication type:
- Article
4
Autophagy is induced by adenoviral-mediated interferon α treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors produced.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 8, p. 579, doi. 10.1038/cgt.2010.14
- By:
- Publication type:
- Article
5
Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 8, p. 585, doi. 10.1038/cgt.2010.15
- By:
- Publication type:
- Article
6
MicroRNA and drug resistance.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 8, p. 523, doi. 10.1038/cgt.2010.18
- By:
- Publication type:
- Article
7
Antisense HIF-1α prevents acquired tumor resistance to angiostatin gene therapy.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 8, p. 532, doi. 10.1038/cgt.2010.7
- By:
- Publication type:
- Article
8
Gemcitabine synergistically enhances the effect of adenovirus gene therapy through activation of the CMV promoter in pancreatic cancer cells.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 8, p. 541, doi. 10.1038/cgt.2010.9
- By:
- Publication type:
- Article